NCT06270771 OURA Ring Wearable Testing in MDS Patients: a Feasibility and Discovery Pilot Study
| NCT ID | NCT06270771 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sunnybrook Health Sciences Centre |
| Condition | MDS |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-03-20 |
| Primary Completion | 2026-03-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2025-03-20 with a primary completion date of 2026-03-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A prospective, single center, single arm phase 2 cohort feasibility study of the OURA ring in adult MDS patients. Patients with MDS will wear the OURA ring and upload biometrics weekly. Quality of life measures will be clinically evaluated and correlated with biometrics. We hypothesize that it will be feasible for MDS patients to wear the OURA ring 70% of the time for 3 months.
Eligibility Criteria
Inclusion Criteria: 1. Provision of signed and dated informed consent form 2. Stated willingness to comply with all study procedures and availability for the duration of the study 3. Male or female, aged 18 or older 4. Able to read, write and speak English or French (non-English or French speaking patients may participate if appropriate translation is used) 5. Diagnosed with Myelodysplastic Syndrome using WHO 2022 criteria (12) all risk groups 6. Ability to wear the OURA ring and operate the associated smart-phone app, and willing to adhere to the study regimen Exclusion Criteria: 1. Performance status ECOG \> 3. 2. Cognitive or physical impairment preventing the usage or utilization of the OURA ring and smart phone.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06270771 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying MDS. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06270771 currently recruiting?
Yes, NCT06270771 is actively recruiting participants. Contact the research team at rena.buckstein@sunnybrook.ca for enrollment information.
Where is the NCT06270771 trial being conducted?
This trial is being conducted at Toronto, Canada.
Who is sponsoring the NCT06270771 clinical trial?
NCT06270771 is sponsored by Sunnybrook Health Sciences Centre. The trial plans to enroll 60 participants.